- Monitor QT in patients on ranolazine and other QT-prolonging drugs.

- Concomitant use of ranolazine and metformin increases metforminÂ levels. Monitor blood glucose and for side effects of metformin in these patients.

- Monitor serum creatinine, BUN, and urine output in patients with CrCl less than 60 ml per minute.

- Monitor for neurologic side effects.